NCT00377312View on ClinicalTrials.gov

7 Day Continuous Parathyroid Hormone IV Infusion

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
OsteoporosisBone Diseases, EndocrineHyperparathyroidism
Interventions
DRUG

Parathyroid Hormone (1-34)

PTH(1-34) IV given over a one week period

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Pittsburgh

OTHER

NCT00377312 - 7 Day Continuous Parathyroid Hormone IV Infusion | Biotech Hunter | Biotech Hunter